overcoming car-t resistance in cll: combining with ibrutinib
Published 7 days ago • 57 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
3:38
mechanisms of resistance to car-t in all: t-cell fitness, antigen loss and immunological rejection
-
1:49
car-t cell approaches in cll: current progress & future directions
-
1:10
combinatorial car-t approaches being explored in multiple myeloma
-
3:07
overcoming resistance to car-t: target upregulation, microenvironment modulation, and novel targets
-
1:40
overcoming antigen escape following cd19-directed car-t therapy
-
1:59
the limitations of car-t currently: overcoming resistance
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
0:37
hot topics in car t-cell therapy for all
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:05
overcoming t-cell exhaustion to improve car-t efficacy in multiple myeloma
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
1:42
challenges associated with car-t cell production
-
4:10
overcoming the limits: bringing car t-cell therapy to the masses
-
3:17
tcxpress™ vs car-t therapy & targeting leukemia with tcr t-cells
-
1:51
regulatory and commercialization challenges with car t-cell therapy
-
3:57
mechanisms and management of short- and long-term car-t toxicities
-
2:43
resistance to car t-cell therapy
-
2:17
overcoming resistance to car-t therapy in cll with ibrutinib & venetoclax